Skip to content
10-Q

Quarterly Report

SIERRA ONCOLOGY, INC.

0001564590-21-054732

← back to feed
Filed
Nov 5, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 1, 2021 15.06M sh
Capex Q3 2021 · Sep 30, 2021 $40K
Capex Q3 2021 · Sep 30, 2020 $12K
Operating Cash Flow Q3 2021 · Sep 30, 2021 −$63.71M
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$39.62M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $97.07M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $104.06M
Cash And Equivalents Q3 2021 · Sep 30, 2020 $109.01M
Stockholders Equity Q3 2021 · Sep 30, 2021 $95.06M
Stockholders Equity Q3 2021 · Jun 30, 2021 $84.27M
Stockholders Equity Q3 2021 · Mar 31, 2021 $101.56M
Stockholders Equity Q3 2021 · Dec 31, 2020 $97.96M
Stockholders Equity Q3 2021 · Sep 30, 2020 $105.36M
Stockholders Equity Q3 2021 · Jun 30, 2020 $116.65M
Stockholders Equity Q3 2021 · Mar 31, 2020 $129.5M
Stockholders Equity Q3 2021 · Dec 31, 2019 $86.35M
Current Liabilities Q3 2021 · Sep 30, 2021 $8.63M
Current Liabilities Q3 2021 · Dec 31, 2020 $9.35M
Total Liabilities Q3 2021 · Sep 30, 2021 $9.17M
Total Liabilities Q3 2021 · Dec 31, 2020 $9.53M
Current Assets Q3 2021 · Sep 30, 2021 $102.72M
Current Assets Q3 2021 · Dec 31, 2020 $106.47M
Total Assets Q3 2021 · Sep 30, 2021 $104.23M
Total Assets Q3 2021 · Dec 31, 2020 $107.49M
Sga Expense Q3 2021 · Sep 30, 2021 $6.99M
Sga Expense Q3 2021 · Sep 30, 2021 $19.27M
Sga Expense Q3 2021 · Sep 30, 2020 $4.11M
Sga Expense Q3 2021 · Sep 30, 2020 $14.92M
Rd Expense Q3 2021 · Sep 30, 2021 $21.62M
Rd Expense Q3 2021 · Sep 30, 2021 $49.72M
Rd Expense Q3 2021 · Sep 30, 2020 $10.43M
Rd Expense Q3 2021 · Sep 30, 2020 $32.21M
Net Income Q3 2021 · Sep 30, 2021 −$28.65M
Net Income Q3 2021 · Sep 30, 2021 −$69.19M
Net Income Q3 2021 · Jun 30, 2021 −$20.63M
Net Income Q3 2021 · Mar 31, 2021 −$19.92M
Net Income Q3 2021 · Sep 30, 2020 −$14.51M
Net Income Q3 2021 · Sep 30, 2020 −$62.88M
Net Income Q3 2021 · Jun 30, 2020 −$16.46M
Net Income Q3 2021 · Mar 31, 2020 −$31.91M
Operating Income Q3 2021 · Sep 30, 2021 −$28.6M
Operating Income Q3 2021 · Sep 30, 2021 −$68.99M
Operating Income Q3 2021 · Sep 30, 2020 −$14.44M
Operating Income Q3 2021 · Sep 30, 2020 −$47.03M
Revenue Q3 2021 · Sep 30, 2020 $100K
Revenue Q3 2021 · Sep 30, 2020 $100K